Research Article
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization
Table 1
Characteristics of all patients with pleural effusion analyzed.
(a) |
| | Healthy controls (h) | | (M: ; F: ) | | Gender | Age | Diagnosis |
| | 1 | M | 45 | Healthy subject | | 2 | M | 61 | Healthy subject | | 3 | M | 57 | Healthy subject | | 4 | M | 57 | Healthy subject | | 5 | M | 65 | Healthy subject | | 6 | M | 46 | Healthy subject | | 7 | M | 76 | Healthy subject | | 8 | M | 46 | Healthy subject | | 9 | F | 47 | Healthy subject | | 10 | F | 59 | Healthy subject | | 11 | F | 65 | Healthy subject | | 12 | F | 70 | Healthy subject | | 13 | F | 58 | Healthy subject | | 14 | F | 62 | Healthy subject |
|
|
Age: mean + SEM = 58.1 + 3.4.
|
(b) |
| | Inflammatory pleural effusion (iPE) | | (M: ; F: ) | | Gender | Age | Diagnosis |
| | 1 | M | 64 | Acute pleurisy | | 2 | F | 74 | Chronic pleurisy | | 3 | M | 45 | Chronic pleurisy | | 4 | M | 72 | Chronic pleurisy | | 5 | M | 74 | Chronic pleurisy | | 6 | M | 80 | Chronic pleurisy | | 7 | M | 80 | Chronic pleurisy | | 8 | M | 83 | Chronic pleurisy | | 9 | M | 85 | Chronic pleurisy | | 10 | M | 59 | Inflammatory pleural effusion | | 11 | M | 72 | Inflammatory pleural effusion | | 12 | M | 77 | Inflammatory pleural effusion | | 13 | F | 75 | Pachypleuritis | | 14 | M | 65 | Pachypleuritis | | 15 | M | 69 | Pachypleuritis | | 16 | M | 71 | Pachypleuritis | | 17 | M | 75 | Pachypleuritis | | 18 | M | 79 | Pachypleuritis |
|
|
Age: mean + SEM = 72.2 + 2.2.
|
(c) |
| | Malignant primary tumor pleural effusion (ptPE) | | (M: ; F: ) | | Gender | Age | Diagnosis |
| | 1 | F | 70 | Epithelioid and sarcomatoid mesothelioma | | 2 | M | 66 | Epithelioid and sarcomatoid mesothelioma | | 3 | F | 66 | Epithelioid mesothelioma | | 4 | F | 77 | Epithelioid mesothelioma | | 5 | F | 82 | Epithelioid mesothelioma | | 6 | M | 49 | Epithelioid mesothelioma | | 7 | M | 52 | Epithelioid mesothelioma | | 8 | M | 73 | Epithelioid mesothelioma | | 9 | M | 73 | Epithelioid mesothelioma | | 10 | M | 80 | Epithelioid mesothelioma | | 11 | F | 80 | Epithelioid mesothelioma | | 12 | F | 90 | Mesothelioma | | 13 | M | 67 | Mesothelioma | | 14 | F | 72 | Mesothelioma | | 15 | F | 79 | Mesothelioma | | 16 | F | 85 | Mesothelioma | | 17 | M | 70 | Mesothelioma | | 18 | M | 79 | Mesothelioma |
|
|
Age: mean + SEM = 72.8 + 2.5.
|
(d) |
| | Malignant tumor metastasis pleural effusion (tmPE) | | (M: ; F: ) | | Gender | Age | Diagnosis |
| | 1 | F | 53 | Hepatocellular carcinoma | | 2 | F | 74 | Ovarian carcinoma | | 3 | M | 82 | Lung squamous cell carcinoma | | 4 | F | 52 | Breast cancer | | 5 | F | 64 | Breast cancer | | 6 | F | 59 | Unknown cell carcinoma | | 7 | F | 73 | Melanoma | | 8 | M | 88 | Neuroendocrine carcinoma | | 9 | F | 68 | Pancreatic cancer | | 10 | F | 49 | Lung adenocarcinoma | | 11 | F | 50 | Lung adenocarcinoma | | 12 | F | 67 | Lung adenocarcinoma | | 13 | F | 68 | Lung adenocarcinoma | | 14 | F | 69 | Lung adenocarcinoma | | 15 | F | 75 | Lung adenocarcinoma | | 16 | F | 79 | Lung adenocarcinoma | | 17 | F | 88 | Lung adenocarcinoma | | 18 | F | 91 | Lung adenocarcinoma | | 19 | M | 46 | Lung adenocarcinoma | | 20 | M | 58 | Lung adenocarcinoma | | 21 | M | 64 | Lung adenocarcinoma | | 22 | M | 70 | Lung adenocarcinoma | | 23 | M | 75 | Lung adenocarcinoma | | 24 | M | 77 | Lung adenocarcinoma | | 25 | M | 78 | Lung adenocarcinoma | | 26 | M | 79 | Lung adenocarcinoma | | 27 | M | 58 | Renal carcinoma |
|
|
Age: mean + SEM = 68.7 + 2.4.
|
